MaRS Monthly Roundup | October

Published on October 3, 2024

From Women in Cleantech cohorts to partnerships and funding round wins, check out the latest MaRS venture success stories.

The post MaRS Monthly Roundup | October appeared first on MaRS Discovery District.

Continue reading on website
Other news

NervGen Pharma Provides Update on Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury

October 1, 2024
Vancouver, BC – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that target enrollment of the chronic cohort in its Phase 1b/2a proof-of-concept, double-blind, randomized placebo-controlled clinical trial (NCT05965700) for its proprietary investigational lead compo

Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing

October 4, 2024
BOSTON & OTTAWA, Ontario--(BUSINESS WIRE)--Ginkgo Bioworks, Inc. (“Ginkgo”) which is building the leading platform for cell programming and biosecurity, and Virica Biotech Inc. (“Virica”), a leading developer of enhancers for scaling of viral vectors as well as cell and gene therapies, today announced a strategic partnership to enhance each company’s adeno-associated virus (AAV) gene therapy manuf